Jan Zetterberg

Jan Zetterberg

Board member since 2020

Education: Law degree 1975. District merit and court law fiscal 1975-1979.

Experience: Jan Zetterberg (born 1951) finished law studies in 1975 after which he worked for the Swedish Court system until 1979. He joined AstraZeneca (Astra) in 1983 where he held several roles such as Legal Counsel, Senior Counsel, Vice President, Strategy, Intellectual Property and since 1999 as Assistant General Counsel.

Jan Zetterberg provided global legal support in all areas of business including corporate functions, R&D, Operations, and Business Development. In addition he was appointed line manager for AstraZeneca Trademarks group in 2008. Jan Zetterberg retired from AstraZeneca in end of 2011. He started Zedur AB in January 2012 to provide consultancy services in the legal and compliance area supporting primarily small to medium size Life Science industry. He became Partner and Chairman of the Board of Zelibra AB in January 2012. Zelibra AB is a Swedish company offering the services of internationally experienced consultants to the life science industry. Its mission is to help bring life science innovations to the right market in a timely and cost-effective manner. In January 2014 Jan Zetterberg was elected Chairman of the Board of ExThera AB.

Independency: Jan Zetterberg is independent in relation to the company, its senior executives and major shareholders.

Shares: 50 000 (incl. related parties).

< Back to the Management< Back to the Board
Scientist working with vaccines in a lab